Development of lanthanide detoxification agents and protocols is of great importance in management of overdoses. Due to safety of maltol as a detoxifying agent in metal overloads, it can be used as a lanthanide detoxifying agent. In order to demonstrate the biodistribution of final complex, [
Introduction
Lanthanides have been used extensively in industry, ophthalmic and camera lenses, petroleum cracking, nuclear reactors, television tubes, and mirrors, to mention a few applications. Symptoms of acute samarium (and other lanthanides) intoxication include defecation, writhing, ataxia, sedation, and labored respiration, which can happen in accidents in reactors and other related industries.
However, not much data are available on the lanthanide detoxification processes of the subjects after acute exposures. Developing lanthanide mobilization protocols using nontoxic and human approved chelators is an interesting field in human health.
Maltol (3-hydroxy-2-methyl-4-pyrone), a common product formed upon heating of carbohydrates, is an approved food additive, used to impart a desirable malty taste and odor to breads, cakes, beer and other beverages ( Figure 1 ). Maltol loses its hydroxyl proton at neutral to basic pH levels, forming the maltolate anion; this anionic molecule forms a strong bidentate/tridentate chelate with gallium, iron, zinc, aluminum, vanadium [1] and lanthanides [2] . Chemical structure of maltol Some of maltolate metal complexes are reported as biologically active compounds including gallium-maltolate for lymphoma treatment [3] . On the other hand aluminummaltolate complex has also demonstrated in vitro apoptotic cell death pathway in man [4] as well as anti-microbial effects [5] .
Maltol and its derivatives have been used in treatment of iron overload disorders such as haemochromatosis and thalassemia major [6] and aluminium toxication [7] .
Due to lanthanide maltol complexes stability reports [8] [9] and is an excellent lanthanide radionuclide for biological studies due to high production yields in research reactors, medium energy beta particles and the existence of photopeak at 103 keV for detection [10] .
Thus, in this work, the preparation, stability tests, partition coefficient determination and comparative biodistribution studies of [
153 Sm]-samarium maltolate as the final product of lanthanide detoxification have been reported.
Results and discussion

Production and quality control of 153 Sm
The radionuclide was prepared in a research reactor according to regular methods with a range of specific activity 22-28 GBq/mg for radiolabeling use, after counting the samples on an HPGe detector for 5 hours, a negligible amount of impurities were recorded and shown to be Eu radionuclides.
The 153 Sm radionuclide in specific activity of 28 GBq/mg was prepared for radiolabeling. The radioisotope diluted and evaporated to obtain the desired pH and volume was followed by sterile filtering. On the other hand, 10% ammonium acetate: methanol mixture was also used for the determination of radiochemical purity. In this solvent system, the fast eluting species were possibly Sm-153 cation, other than Sm 3+ (2%) and the remaining fraction at R f .0 was a possible mixture of Sm 3+ and/or colloids. The difference in values of impurity in two solvent systems is possibly due to the presence of colloidal impurity in the sample (2%) ( Tables 1, 2) .
Preparation of 153 Sm-MAL
In order to obtain the highest specific activity in the shortest possible time, a quantitative study was designed using different amounts of MAL and various time intervals for a specific amount of radioactivity while 60°C was considered a suitable temperature. A satisfactory labeling yield of 99-100% was obtained at this temperature using 20-30 mg of MAL within 2 h.
Because of relative lipophilic [
153 Sm]-samarium maltolate complex and participation of several polar functional groups in its structure, [
153 Sm]-samarium maltolate migrated to the solvent frontline in ITLC while 153 Sm cation was retained in origin ( Table 1 ). The labeling step took about 2 h. In all radiolabeling procedures (n=5), the labeling yield was over 99% (Table 2) .
Tab. 2.
Purities for radioactive samples used in this study (n=5) The partition coefficient for the labeled compound was calculated (logP. 1.869) demonstrating a rather lipophilic complex as it could be observed from the chromatographic behavior.
The final radiolabeled complex diluted in normal saline was then passed through a 0.22 µm (Millipore) filter for sterilization. Incubation of [ 153 Sm]-samarium maltolate in freshly prepared human serum for 24 h at 37°C showed no loss of 153 Sm from the complex.
Biodistribution studies for 153 Sm cation in wild-type rats
The animals were killed by CO 2 asphyxiation at selected times after injection (2, 4, 24 and 48h). Dissection began by drawing blood from the aorta followed by removing the heart, spleen, muscle, bone, kidneys, liver, intestine, stomach, lungs and skin samples. The tissue uptakes were calculated as the percent of area under the curve of the related photo peak per gram of tissue (% ID/g) ( Table 3 ).
The liver uptake of the cation is comparable with many other radio-lanthanides mimicking calcium cation accumulation; about %3 of the activity accumulates in the liver after 48 h. The transferin-metal complex uptake and the final liver delivery seems the possible route of accumulation.
The blood content is low at all time intervals and this shows the rapid removal of activity in the circulation. The lung, muscle and also skin do not demonstrate significant uptake which is in accordance with other cations accumulation. A %4 bone uptake is observed for the cation which remains almost constant after 96 h (data not shown). The spleen also has a significant uptake possibly related to reticuloendothelial uptake. The kidney plays an important role in 153 Sm cation excretion especially after 24 h. Regarding the blood activity content, the Sm cation content is almost intact in 48 hours which can be a result of metal-serum protein interactions, while in case of [ 153 Sm]-samarium maltolate, the activity is rapidly decreased in 24 hours and reaches its minimum in 48 hours (Table 4) . This is a significant detoxifying property for maltol in the presence of radiolanthanides.
Fig. 2.
Comparative %ID/g in the blood for [ 153 Sm]-samarium maltolate (labeled, red) and 153 SmCl 3 (free, blue) in wild-type rats
Regarding the kidney activity content, both species are excreted from the kidneys; the excretion difference is not significant (Figure 3) . The bone activity content, is always a major problem in lanthanide overdose. The Sm cation content is almost higher at all time intervals compared with the labeled compound and in 48 hours almost no activity (less than 0.4%) can be observed in the bones (Fig. 4) . The liver activity content is another major problem in lanthanide overdoses. The Sm cation content is almost less in the first few hours while after 24 h it is constant at around %3. The whole liver activity decreases to less than %2 in 48 hours which is a satisfactory activity reduction for detoxification process ( Figure 5 ).
Considering the whole-body activity content, an accumulative activity was calculated for the [ 153 Sm]-samarium maltolate among the tissues in 4-48 time period. A polynominal curve can be fitted to the time-activity data with high R-square value (R 2 =1). Considering the half activity of the starting time interval (4h, 11.1178 %ID/g), a biological half-life for the complex can be determined by dissolving the equation (at x=5.55). Thus the effective half life of about 2.3 h is calculated for the complex. While the biological half life can be calculated (T1/2 biol. 2.46).
Fig. 6.
Whole-body activity content/time curve for [ 153 Sm]-samarium maltolate in 4-48 time period in wild-type rats
Experimental
Production of 153 Sm was set up at Tehran Research Reactor (TRR) using 152 Sm (n, γ) 153 Sm reaction with 152 Sm in purity of 98.7% (ISOTEC Inc.). Maltol was purchased from Aldrich Co., Germany, without further purification. Chromatography paper (Whatman No. 2) was obtained from Whatman (Maidstone, UK). Radio-chromatography was performed using a bioscan AR-2000 radio TLC scanner instrument (Bioscan, Paris, France). A high purity germanium (HPGe) detector coupled with a Canberra™ (model GC1020-7500SL) multichannel analyzer and a dose calibrator ISOMED 1010 (Dresden, Germany) were used for counting distributed activity in rat organs. All other chemical reagents were purchased from Merck (Darmstadt, Germany). Calculations were based on the 103 keV peak for 153 Sm. All values were expressed as mean ± standard deviation (Mean ± SD) and the data were compared using Student's T-test. Statistical significance was defined as P<0.05. Animal studies were carried out in accordance with the United Kingdom Biological Council's Guidelines on the Use of Living Animals in Scientific Investigations, 2nd ed. Male healthy rats were purchased from Pasteur Institute, Tehran, Iran.
Production and quality control of 153 SmCl 3 solution
The 153 Sm was produced by neutron irradiation of 100 µg of enriched 152 Sm 2 O 3 according to reported procedures [11] at a thermal neutron flux of 5×10 13 n.cm -2 .s −1 for 5 days. Specific activity of the 153 Sm was 27.75 GBq/mg. The irradiated target was dissolved in 200 µl of 1.0 mol/L HCl, to prepare 153 SmCl 3 and diluted to the appropriate volume with ultra pure water, to produce a stock solution. The mixture was filtered through a 0.22 µm biological filter and sent for use in the radiolableing step. Radionuclidic purity of the solution was tested for the presence of other radionuclides using beta spectroscopy and HPGe spectroscopy to detect various interfering beta and gamma emitting radionuclides. The radiochemical purity was also checked by Whatman No.2 chromatography paper, and developed in a mixture of 10 mmol/L DTPA solution as a mobile phase.
Labeling maltolate with
153 SmCl 3 The labeling was developed in ethanolic media. Briefly, 153 SmCl 3 (111 MBq, 0.1 ml) was added to a borosilicate vial and dried by warming (50°C) under a nitrogen flow for about 15 minutes. Then, maltol (30mg, 0.25 mmol) dissolved in absolute ethanol (1 ml) was added to the dried residue and the mixture agitated and incubated at 60°C for 2 hours. The radiochemical purity of free samarium and Sm-MAL were determined by counting Whatman No.2 sheets as stationary phase using various mobile phases (A: ammonia:water:methanol (2:40:20), B: 1mM DTPA aqueous solution, C: %10 ammonium acetate:methanol system, 1:1). After obtaining the desired radiochemical purity, the ethanolic solution was concentrated by warming 40-50°C to 0.05 ml and then diluted to a 5% solution by adding 1 ml of normal saline.
Stability testing of the radiolabeled compound in aqueous solution
Stability of [
153 Sm]-samarium maltolate in final preparation was determined by storing the final solution at 25°C for 24 h and performing frequent ITLC analysis using ammonia:water:methanol (2:40:20) mobile phase to determine radiochemical purity.
153 Sm]-samarium maltolate in presence of human serum
Final [
153 Sm]-samarium maltolate solution (7.5 MBq, 50 µl) was incubated in the presence of freshly prepared human serum (300 µl) and kept at 37°C for 2 days. The complex stability was assessed by performing frequent ITLC analysis using ammonia:water:methanol (2:40:20) mobile phase to determine radiochemical purity.
Determination of Partition coefficient
The partition coefficient of the [
153 Sm]-samarium maltolate was measured following 1 min of vigorous vortex mixing of 1 ml of 1-octanol and 1 ml of isotonic acetate-buffered saline (pH=7) with approximately 3.7 MBq of the radiolabeled complex at 37°C. Following further incubation for 5 min, the octanol and aqueous phases were sampled and counted in an automatic well counter. A 500 µl sample of the octanol phase from this partitioning was repartitioned two to three times with fresh buffer to ensure that traces of hydrophilic 153 Sm impurities did not alter the calculated P values. The reported log P values are the average of the second and third extractions from three to four independent measurements, log P values represent the mean (standard deviation) of five measurements.
Biodistribution of [
153 Sm]-samarium maltolate and 153 SmCl 3 in normal rats
To determine comparative biodistribution, [ 153 Sm]-samarium maltolate and 153 SmCl 3 were administered to normal rats in separate groups (n=3). A volume (100-120 μl) of final [ 153 Sm]-samarium maltolate solution (4800±185 KBq) radioactivity was injected intravenously to rats through their tail vein. The animals were sacrificed at the exact time intervals (2, 4, 24 hours and 48 h), and specific activity of different organs was calculated as percentage of injected dose per gram using HPGe detector.
